Cargando…
Is antithrombin treatment of disseminated intravascular coagulation a quixotic goal?
The development of disseminated intravascular coagulation (DIC) is associated with increased sepsis mortality. Antithrombin (AT) is one of several anticoagulants that have been studied in randomized trials of sepsis without benefit. In a recent study, Iba and colleagues reviewed data from patients w...
Autores principales: | Seam, Nitin, Suffredini, Anthony F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4331332/ https://www.ncbi.nlm.nih.gov/pubmed/25673027 http://dx.doi.org/10.1186/s13054-014-0639-1 |
Ejemplares similares
-
Management of disseminated intravascular coagulation: current insights on antithrombin and thrombomodulin treatments
por: Hayakawa, Mineji
Publicado: (2017) -
Association of antithrombin with development of trauma-induced disseminated intravascular coagulation and outcomes
por: Wada, Takeshi, et al.
Publicado: (2022) -
Efficacy of antithrombin in preclinical and clinical applications for sepsis-associated disseminated intravascular coagulation
por: Iba, Toshiaki, et al.
Publicado: (2014) -
Antithrombin III concentrate may contribute to sepsis in nonovert disseminated intravascular coagulation
por: Saito, Noriko, et al.
Publicado: (2013) -
Use of Antithrombin and Thrombomodulin in the Management of Disseminated Intravascular Coagulation in Patients with Acute Cholangitis
por: Nakahara, Kazunari, et al.
Publicado: (2013)